Literature DB >> 1825187

Cytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with systemic lupus erythematosus.

B K Pelton1, M Speckmaier, W Hylton, J Farrant, A M Denman.   

Abstract

B lymphocytes from patients with systemic lupus erythematosus (SLE) secreted high levels of immunoglobulin spontaneously when cultured in vitro. Addition of the cytokines interleukin-2, interleukin-4 and interleukin-6 either alone or in combination failed to augment spontaneous immunoglobulin synthesis. Percoll-separated low-density SLE B lymphocytes matured into immunoglobulin-secreting cells also independent of exogenous interleukins. During maturation these cells became enlarged and less dense, and began to express CD23. This was in contrast to normal B cells, which did not secrete immunoglobulin spontaneously but synthesized IgM after interleukin stimulation. These results indicate that in vitro immunoglobulin synthesis by SLE B cells is already initiated in these cells and progresses independently of further stimulatory manoeuvres.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825187      PMCID: PMC1535253          DOI: 10.1111/j.1365-2249.1991.tb05627.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Serum levels of interferons in patients with systemic lupus erythematosus.

Authors:  T Kim; Y Kanayama; N Negoro; M Okamura; T Takeda; T Inoue
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

Review 2.  Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes.

Authors:  P Casali; A L Notkins
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  The effect of interleukin 1 on IgG synthesis in systemic lupus erythematosus.

Authors:  R C Jandl; J L George; C A Dinarello; P H Schur
Journal:  Clin Immunol Immunopathol       Date:  1987-12

4.  Autoantibodies to intracellular proteins in human systemic lupus erythematosus are not due to random polyclonal B cell activation.

Authors:  A E Gharavi; J L Chu; K B Elkon
Journal:  Arthritis Rheum       Date:  1988-11

5.  Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cells.

Authors:  J Farrant; A E Bryant; A M Lever; A J Edwards; S C Knight; A D Webster
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

6.  Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells.

Authors:  M Linker-Israeli; A C Bakke; F P Quismorio; D A Horwitz
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  T helper cell-induced CD23 (BLAST-2) expression: an activation marker for the high density fraction of human B cells.

Authors:  J A Jover; E K Chartash; B Kushner; S M Friedman; M K Crow
Journal:  Clin Immunol Immunopathol       Date:  1989-10

8.  CD23: a multi-functional receptor/lymphokine?

Authors:  J Gordon; L Flores-Romo; J A Cairns; M J Millsum; P J Lane; G D Johnson; I C MacLennan
Journal:  Immunol Today       Date:  1989-05

9.  Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression.

Authors:  Y Tanaka; K Saito; H Suzuki; S Eto; U Yamashita
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

10.  Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors.

Authors:  J Bujanowski-Weber; B Brings; I Knöller; T Pfeil; W König
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

View more
  6 in total

Review 1.  Hypergammaglobulinaemia and autoimmune rheumatic diseases.

Authors:  M R Ehrenstein; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

Review 2.  The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.

Authors:  D A Horwitz; C O Jacob
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  B K Pelton; W Hylton; A M Denman
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

4.  Spontaneous immunoglobulin-producing capacity of cultures from lupus patients and normal donors following depletion of cells expressing CD19 or CD38.

Authors:  T Bourne; M Zukowska-Cooper; M R Salaman; M H Seifert; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

Review 5.  Abnormalities in the regulation of variable region genes that encode for antibodies to DNA may be a central factor in the pathogenesis of systemic lupus erythematosus.

Authors:  A K Singh
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

6.  Advances in human B cell phenotypic profiling.

Authors:  Denise A Kaminski; Chungwen Wei; Yu Qian; Alexander F Rosenberg; Ignacio Sanz
Journal:  Front Immunol       Date:  2012-10-10       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.